Jefferies Drops Price Target After ResMed (RMD) Heart Failure Trial Fails
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq hits record high as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| RESMED, Inc. (NYSE: RMD) | Delayed: 223.16 +4.27 (1.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $218.89 | 52 Week High | $70.90 | |||
| Open | $218.44 | 52 Week Low | $50.77 | |||
| Day High | $223.45 | P/E | 100.07 | |||
| Day Low | $218.44 | EPS | $2.23 | |||
| Volume | 420,847 | |||||
